Previous Article | Next Article ![]()
J. Virol., 02 1995, 796-800, Vol 69, No. 2
F Baldanti, E Silini, A Sarasini, CL Talarico, SC Stanat, KK Biron, M Furione, F Bono, G Palu and G Gerna
Multiple human cytomegalovirus (HCMV) strains frequently coexist in
patients with AIDS, and chronic ganciclovir treatment may favor the
emergence of ganciclovir-resistant viral mutants. We report the molecular
and biochemical characterization of a HCMV ganciclovir- resistant strain
(VR3480) previously recovered from a patient with AIDS who was undergoing
multiple courses of ganciclovir treatment (G. Gerna, F. Baldanti, M.
Zavattoni, A. Sarasini, E. Percivalle, and M. G. Revello, Antiviral Res.
19:333-345, 1992). Ganciclovir resistance of strain VR3480 was related to
impaired ability to monophosphorylate the drug, as indicated by the finding
that ganciclovir phosphorylation values for VR3480 were 30% of those shown
by the HCMV reference strain AD169 in an in vitro activity assay.
Sequencing of the UL97 gene of VR3480, which encodes the viral kinase
responsible for ganciclovir phosphorylation, showed an in-frame deletion of
three nucleotides resulting in the loss of a leucine at position 595 in the
polypeptide. Mutant VR3480 UL97 DNA was able to transfer resistance to the
AD169 strain in marker rescue experiments. Analysis of virus isolates and
blood polymorphonuclear leukocyte samples spanning the 2-year follow-up
period of the patient showed that ganciclovir-resistant strain VR3480 arose
ex novo during prolonged antiviral treatment and accounted for the majority
of virus load circulating in blood during the period of clinical resistance
to ganciclovir treatment.
Copyright © 1995, American Society for Microbiology
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate
Virus Laboratory, University of Pavia, IRCCS Policlinico S. Matteo, Italy.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|